Home
>
National Drug Code (NDC)
>
Felbamate
Felbamate - 51525-0430-1 - (felbamate)
Drug Information of Felbamate
| Product NDC: | 51525-0430 |
| Proprietary Name: | Felbamate |
| Non Proprietary Name: | felbamate |
| Active Ingredient(s): | 400 mg/1 & nbsp; felbamate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Felbamate
| Product NDC: | 51525-0430 |
| Labeler Name: | Wallace Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020189 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20111111 |
Package Information of Felbamate
| Package NDC: | 51525-0430-1 |
| Package Description: | 100 TABLET in 1 BOTTLE (51525-0430-1) |
NDC Information of Felbamate
| NDC Code | 51525-0430-1 |
| Proprietary Name | Felbamate |
| Package Description | 100 TABLET in 1 BOTTLE (51525-0430-1) |
| Product NDC | 51525-0430 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | felbamate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111111 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Wallace Pharmaceuticals Inc. |
| Substance Name | FELBAMATE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
